Status: Public Comment
Sponsoring Committee: Operations and Safety
Strategic Goal: Promote living donor and transplant recipient safety
Read the proposal (PDF; 01/2020)
Contact: Pete SokolSubmit a comment
Click on the Submit a comment button above to provide your feedback. Your comments relating to the proposal will be displayed in the comment section below (within 24 hours).
No other identifying information will be displayed unless you choose to display your name with the comment. You can also submit a comment anonymously. You may submit comments by email, fax or mail.
At a glance
What is current policy and why change it?
Currently, host Organ Procurement Organizations (OPOs) must ensure two donor blood type samples are used to determine blood type. They also must develop and comply with written procedures to resolve any conflicts with results and to verify key information prior to organ recovery.
Recent reports of events affecting patient safety led to the decision to re-evaluate the requirements for blood type determination.
What’s the proposal?
- Require host OPOs, transplant programs, and recovery hospitals (for living donors) to include a process in their written protocols for addressing indeterminate blood typing results.
- Require host OPOs to document all blood products the donor received since admission to the donor hospital.
- Align deceased donor, candidate, and living donor policies.
What’s the anticipated impact of this change?
- What it’s expected to do
- Trigger updates of written protocols to include plan for “indeterminate” results.
- Provide more thorough policy guidance to ensure patient safety.
- Changes to the candidate and living donor policies to provide consistency in policy language.
- What it won’t do
- This proposal will not specify a comprehensive list of information that should be included in protocols and procedures for OPOs or transplant programs.
Themes to consider
- Living Donor Safety
- Recipient Safety
- Blood Type Verification
Terms you need to know
- ABO Blood Type: The classification of human blood into four groups: A, B, AB, and O.
- Blood Products: Any therapeutic substance prepared from human blood. This includes: whole blood, blood components, and plasma.
- Conflicting: Two blood tests from the same donor or candidate that show different blood types.
- Indeterminate: A blood test that does not provide a clear result.
- Organ Procurement Organization: An organization designated by the Centers for Medicare and Medicaid Services (CMS) and responsible for the procurement of organs for transplantation and the promotion of organ donation.
- Protocol: A predefined written procedural method.
- Transplant Center: A hospital that performs transplants, including qualifying patients for transplant, registering patients on the national waiting list, performing transplant surgery and providing care before and after transplant.
- Click here to search the OPTN glossary